Early Access Program - Kisqali / Ribociclib for EBC

Hi @PCK
I stayed on the current formulation of Kisqali - but have just come off it due to liver problems.
I was on an early access program - it wasn't covered by Medicare, is very expensive but was only the standard script cost for me ($31.60).
I don't see my med onc till early November and will discuss then whether or not I go onto a differenct CDK4/6 inhibitor.
Let me know how you go - and best of luck.
Kelly